Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

Abhishek Bhat; Sanoj Punnen

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

Urology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	235-236
Number of pages	2
Journal	Oncology (Williston Park, N.Y.)
Volume	33
Issue number	6
State	Published - Jun 19 2019

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{3b08d03f852e48598d6a9deca96b988d,

title = "Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?",

author = "Abhishek Bhat and Sanoj Punnen",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2019",

month = jun,

day = "19",

language = "English (US)",

volume = "33",

pages = "235--236",

journal = "ONCOLOGY (United States)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "6",

}

TY - JOUR

T1 - Point

T2 - Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

AU - Bhat, Abhishek

AU - Punnen, Sanoj

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2019/6/19

Y1 - 2019/6/19

UR - http://www.scopus.com/inward/record.url?scp=85068485466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068485466&partnerID=8YFLogxK

M3 - Article

C2 - 31219609

AN - SCOPUS:85068485466

VL - 33

SP - 235

EP - 236

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

SN - 0890-9091

IS - 6

ER -

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this